Stay updated on CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record view now shows a 403 Forbidden message with a Home button, and the site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-11-01T02:03:21.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A banner announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.
    Difference
    1%
    Check dated 2026-10-25T02:02:30.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision marker changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T01:43:47.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:10:14.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the study content and indicating access restrictions rather than updates to the record.
    Difference
    18%
    Check dated 2026-09-20T01:01:40.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from v3.6.5 to v3.6.6, indicating a newer revision of the study record content.
    Difference
    0.1%
    Check dated 2026-08-29T21:59:11.000Z thumbnail image

Stay in the know with updates to CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CT-P10 vs Rituxan in Low Burden Follicular Lymphoma Clinical Trial page.